Nielsen, Jacob,Farah, Mohamed M.,Kehler, Jan,Kilburn, John Paul,Langgard, Morten,Ritzen, Andreas
申请号：
AU2009259209
公开号：
AU2009259209B2
申请日:
2009.06.19
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective, amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).
